Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $1.4B | $1.47B | -4.96% |
Cost of Revenue | $937.3M | $907.7M | +3.26% |
Gross Profit | $460.2M | $562.7M | -18.22% |
Operating Income | $249M | $337.8M | -26.29% |
Net Income | $111.3M | $155.1M | -28.24% |
EPS (Basic) | $3.09 | $3.96 | -21.97% |
EPS (Diluted) | $3.06 | $3.91 | -21.74% |
R&D Expense | $35.1M | $33.6M | +4.46% |
SG&A Expense | $169.7M | $174.4M | -2.69% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $3.49B | $3.67B | -4.91% |
Current Assets | $1.48B | $1.87B | -20.87% |
Total Liabilities | $912.6M | $922.9M | -1.12% |
Current Liabilities | $633.7M | $511.6M | +23.87% |
Stockholders' Equity | $2.58B | $2.75B | -6.19% |
Cash & Equivalents | $446.2M | $796.3M | -43.97% |
Long-Term Debt | $205.8M | $207.8M | -0.96% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $283.2M | $307.3M | -7.84% |
Investing Cash Flow | $-191.8M | $-164.2M | -16.81% |
Financing Cash Flow | $-489.3M | $-247.8M | -97.46% |
Share Buybacks | $454.1M | $233.5M | +94.48% |
D&A | $74.5M | — | — |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Gross Margin | 32.9% | 38.3% | -5.34% |
Operating Margin | 17.8% | 23.0% | -5.16% |
Net Margin | 8.0% | — | — |
ROE | 4.3% | — | — |
ROA | 3.2% | — | — |
Current Ratio | $2.34 | — | — |
Debt to Equity | $0.354 | — | — |
Other companies in Life Sciences Tools & Services